Telix Pharmaceuticals Recruits Kevin Richardson as CEO Telix Americas
- Telix Pharmaceuticals (TLX) appoints Kevin Richardson to the role of CEO Telix Americas
- The senior global executive will step into the position from today, bringing with him 25 years of experience in the healthcare industry
- Mr Richardson most recently held the role of Chief Operating Officer of UroShape Medical
- Dr Christian Behrenbruch, Group CEO and Managing Director, says Kevin brings a new depth of sales and marketing experience to the company’s U.S. operations
- TelixPharmaceuticals ends the 0.37 per cent in the red to close at $5.45
